Stem cells are undifferentiated cells that can give rise to a wide variety of specialized cell types. In development and tissue maintenance, these cells play crucial roles in maintaining homeostasis and reproductive fitness. The C. elegans germline is set up in an assembly line-like format, in which mitotically dividing proliferative cells, or stem cells, reside in a distal niche. As cells move away from this niche, they gradually progress through meiosis until ultimately becoming fully differentiated sperm or oocytes. Notch signaling in the distal end of the germline provides the proliferative signal, while downstream post-transcriptional regulatory pathways promote differentiation. Although this main pathway has been well characterized, there exist various components that serve to fine-tune this balance in subtle but important ways. Previous work has identified small RNA molecules, such as miRNAs, as having a role in germline stem cell regulation. Here, the role of
vig-1, a gene involved in the RNA-induced silencing complex (RISC) pathway, in C. elegans germline stem cell regulation is investigated. Although
vig-1 performs multiple functions in a variety of tissues, it was initially implicated in the germline through its physical protein interaction with another RISC component,
teg-1, that was known to modulate germline stem cell balance. We show that
vig-1 likely functions to repress the activity of Notch signaling. Genetic null mutants for
vig-1 and GLD-1/GLD-2 pathway components do not cause any changes to germline phenotype, suggesting that
vig-1 does not function downstream of Notch. However, in worms that lack
vig-1 activity, Notch signaling is seen to be enhanced, manifesting through ectopic mitotic activity and over-proliferation of stem cells. In addition,
vig-1 can partially suppress Notch loss-of-function mutant phenotypes. In addition, we show that
vig-1 may act directly on Notch signaling through increasing the expression of its direct transcriptional targets, LST-1 and SYGL-1. Finally, we propose that
vig-1 acts through modulating miRNA levels, as germline miRNA levels are reduced in
vig-1 mutants.